š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study is to compare a needle-free treatment of hypoglyc...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Start Date
2017-11-10
Trial ID
NCT03339453
Treatments Being Tested
The purpose of this study was to assess how glucagon administered nasally, ...
Status
Completed
Location
Barbara Davis Center for Diabetes
Start Date
2013-11
Trial ID
NCT01997411
Treatments Being Tested
The purpose of this study is to assess the efficacy, pharmacokinetics (PK),...
Status
Completed
Location
Barbara Davis Center for Diabetes
Start Date
2013-11
Trial ID
NCT01994746
Treatments Being Tested
The aim of this study is to evaluate the growth hormone (GH) and adrenocort...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT02240043
Treatments Being Tested
This study involves taking a single dose of 100 milligrams (mg) or 300 mg L...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-07
Trial ID
NCT01640834
The purpose of this study is to evaluate the pharmacokinetics and pharmacod...
Status
Completed
Location
Charles River Laboratories
Start Date
2007-08
Trial ID
NCT00745186
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of nasal ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2018-02-21
Trial ID
NCT03421379
Treatments Being Tested
Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by prog...
Status
Not Yet Recruiting
Location
Ministry of Health Medical City
Start Date
2027-01-01
Trial ID
NCT07614412
Treatments Being Tested
This study provides information on immunogenicity of Nasal Glucagon (AMG504...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2013-09
Trial ID
NCT01959334
Treatments Being Tested
The purpose of this study is to determine whether the administration of pro...
Status
Completed
Location
Neonatal Intensive Care Unit - Azienda Ospedaliero-Universitaria Meyer
Start Date
2010-01
Trial ID
NCT01079715
Treatments Being Tested